Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Plerixafor

EU orphan designation number: EU/3/14/1403   
Active ingredient: Plerixafor
Indication: Treatment of WHIM syndrome
Sponsor: Groupe d'étude des neutropénies
Service hémato oncologie, Hopital Trousseau, 26 Avenue du Docteur Arnold Netter, 75012 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/12/2014 Orphan designation EMA/OD/190/14 (2014)10051 of 16/12/2014